Prospective Case Series — Forward-Looking Observational Study of a Patient Group
Prospective Case Series Study · Also known as: prospective case series study, forward-looking case series, prospective uncontrolled study, prospective observational case series
A prospective case series is an observational study design in which a group of patients with a particular condition, exposure, or intervention is identified in advance and followed forward in time according to a pre-specified protocol. Data on outcomes, adverse events, and clinical course are collected as they occur, yielding higher data quality and temporal clarity than retrospective designs. No control group is included, so causal inference is limited, but the design is valuable for characterizing natural disease history, early safety signals, and feasibility of new interventions.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Use a prospective case series when you need a rigorous forward-looking description of a patient group and a randomized controlled trial or cohort study with a control group is not yet feasible — for example, during early evaluation of a novel surgical technique, device, or rare-disease treatment. The design is well suited to documenting natural history, estimating incidence of adverse events, and generating hypotheses for future controlled studies. Do NOT use it when the research question requires causal attribution (e.g., whether a treatment is more effective than another), when prevalence or incidence in the general population is the target, or when a well-conducted RCT or cohort study is already achievable — those designs provide far stronger evidence. Also avoid this design when the condition is so common and the intervention so established that a controlled trial is ethically and practically mandatory.
Strengths & limitations
- Prospective data collection eliminates recall bias and allows standardized, pre-specified measurement protocols.
- Temporal sequence of exposure and outcome is clear, supporting mechanistic reasoning even without a control group.
- Well-suited to rare conditions or novel interventions where a concurrent control group cannot be assembled.
- Generates detailed, high-quality descriptive data on safety, feasibility, and clinical course to inform the design of future controlled studies.
- Relatively straightforward to design and conduct compared to randomized trials; lower regulatory burden for observational series.
- Absence of a control group means the design cannot establish whether outcomes differ from what would have occurred without the intervention or exposure.
- Results are not generalizable beyond the specific case mix and clinical context of the enrolled series.
- Susceptible to selection bias if enrollment is not consecutive or eligibility criteria are applied inconsistently.
- Losses to follow-up can seriously bias outcome estimates if attrition is not random or if incomplete cases are excluded.
Frequently asked
How is a prospective case series different from a prospective cohort study?
Both collect data going forward in time, but a cohort study includes at least two comparison groups (exposed vs. unexposed, or treated vs. untreated) so that relative risks can be estimated. A prospective case series has only one group — all patients share the characteristic of interest — and is limited to descriptive outcomes without a built-in comparator.
What is the minimum sample size for a prospective case series?
There is no universal minimum, but clinical epidemiology guidance suggests that for detecting safety signals, n = 3/p (where p is the expected adverse event rate) provides 95% confidence of observing at least one event. For feasibility or descriptive purposes, 20–50 patients is commonly cited as a practical lower bound. The required size depends on the precision needed for the primary outcome estimate.
Should I pre-register a prospective case series?
Yes. Prospective registration in a clinical trial registry (e.g., ClinicalTrials.gov) or observational study registry (e.g., ISRCTN) before enrollment begins is strongly recommended by journals and regulatory bodies. Registration documents the protocol, eligibility criteria, and primary outcomes in advance, protecting against outcome-switching and increasing credibility of the findings.
Which reporting guideline applies to prospective case series?
The CARE guidelines (Gagnier et al., 2013/2016) were developed primarily for individual case reports but are frequently applied to small series. For larger series the STROBE statement (Strengthening the Reporting of Observational Studies in Epidemiology) is more appropriate. Some journals require CONSORT extensions for uncontrolled studies. Check the target journal's instructions for authors.
Can a prospective case series support regulatory approval of a new treatment?
Occasionally — regulatory agencies such as the FDA and EMA may accept prospective series as the primary evidence base for treatments of rare diseases (orphan indications) where randomized trials are not feasible, particularly when the treatment effect is very large and the natural history without treatment is well characterized. This is an exception rather than the rule; controlled designs are generally required for regulatory approval.
Sources
- Meinert, C. L. (1996). Clinical Trials: Design, Conduct, and Analysis. Oxford University Press. ISBN: 978-0195035681
- Gagnier, J. J., Kienle, G., Altman, D. G., Moher, D., Sox, H., Riley, D., & the CARE Group. (2016). The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development. Global Advances in Health and Medicine, 2(5), 38-43. DOI: 10.7453/gahmj.2013.008 ↗
How to cite this page
ScholarGate. (2026, June 3). Prospective Case Series Study. ScholarGate. https://scholargate.app/en/epidemiology/prospective-case-series
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Case seriesEpidemiology↔ compare
- Cohort StudyEpidemiology↔ compare
- Diagnostic Accuracy Study DesignClinical Research↔ compare
- Prospective Cohort StudyEpidemiology↔ compare
- Retrospective Case SeriesEpidemiology↔ compare